Ustekinumab Maintained Clinically Meaningful Improvement in Health-Related Quality of Life in Patients With Moderate to Severe Crohn's Disease: Results From the IM-UNITI Long-Term Extension

被引：0
|
作者：
Sands, Bruce E. [1 ]
Han, Chenglong [2 ]
Gasink, Christopher [3 ]
Bin, Zou [4 ]
Stephen, Targan [5 ]
Sandborn, William J. [6 ]
Feagan, Brian G. [7 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Janssen Global Serv LLC, Malvern, PA USA
[3] Janssen Sci Affairs LLC, Horsham, PA USA
[4] Janssen Res & Dev LLC, Spring House, PA USA
[5] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[6] Univ Calif San Diego, La Jolla, CA 92093 USA
[7] Robarts Clin Trials, London, ON, Canada
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
690
引用
收藏
页码：S404 / S404
页数：1
相关论文
共 50 条
  • [21] Relationship Between Hospitalization, Surgery and Achievement of Clinical Remission or Clinical Response in Moderate to Severe Crohn's Disease Patients: Results From the UNITI/IM-UNITI Trials
    Ding, Zhijie
    Kachroo, Sumesh
    Izanec, James
    Naessens, Dominik
    Fischer, Claire
    Gauthier, Aline
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S684 - S684
  • [22] Ustekinumab Improves General Health Status and Disease-Specific Health Related Quality of Life of Patients with Moderate to Severe Crohn's Disease: Results from the UNITI and IMUNITI Phase 3 Clinical Trials
    Sands, Bruce E.
    Han, Chenglong
    Gasink, Christopher
    Szapary, Philippe
    Gao, Long-Long
    Lang, Yinghua
    Feagan, Brian G.
    GASTROENTEROLOGY, 2016, 150 (04) : S1004 - S1004
  • [23] A Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Ustekinumab Maintenance Therapy in Moderate - Severe Crohn's Disease Patients: Results From IM-UNITI
    Sandborn, William
    Feagan, Brian G.
    Gasink, Christopher
    Jacobstein, Douglas
    Gao, Long-Long
    Johanns, Jewel
    Sands, Bruce E.
    Hanauer, Stephen B.
    Targan, Stephan
    Ghosh, Subrata
    de Villiers, Willem J.
    Colombel, Jean-Frederic
    Lee, Scott
    Dieleman, Levinus A.
    Katz, Seymour
    Rutgeerts, Paul J.
    GASTROENTEROLOGY, 2016, 150 (04) : S157 - S158
  • [24] Effectiveness and Safety of Mirikizumab after switching from Ustekinumab in patients with moderate to severe Crohn's disease: results from a long-term extension study
    D'Haens, G.
    Laharie, D.
    Dulai, P. S.
    Seibold, F.
    Siegmund, B.
    Abraham, B.
    Malter, L.
    Protic, M.
    Morris, N.
    Hozak, R. R.
    Moses, R. E.
    Lopes, M. Ugolini
    Durand, F.
    Yu, G.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i168 - i170
  • [25] Ustekinumab improves health-related quality of life in patients with moderate-to-severe Crohn's disease: results up to Week 48 of the STARDUST trial
    Danese, S.
    Vermeire, S.
    D'Haens, G.
    Panes, J.
    Dignass, A.
    Magro, F.
    Nazar, M.
    Le Bars, M.
    Lahaye, M.
    Ni, L.
    Bravata, I.
    Gaya, D. R.
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S330 - S331
  • [26] Ustekinumab improves health-related quality of life in patients with moderate-to-severe Crohn's disease: Results up to Week 104 of the STARDUST trial
    Panes, Julian
    Vermeire, Severine R.
    D'Haens, Geert
    Danese, Silvio
    Magro, Fernando
    Nazar, Maciej
    Le Bars, Manuela
    Lahaye, Marjolein
    Ni, Lioudmila
    Bravata, Ivana R.
    Gaya, Daniel
    Peyrin-Biroulet, Laurent
    Dignass, Axel
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2023, 11 (05) : 410 - 422
  • [27] HEALTH-RELATED QUALITY OF LIFE IN ITALIAN PATIENTS WITH MODERATE AND SEVERE CROHN'S DISEASE: INTERIM RESULTS FROM THE SOLE STUDY
    Lazzaro, C.
    Cappello, M.
    Cortelezzi, C.
    Costantino, G.
    Fiorino, G.
    Mastronardi, M.
    Giannotta, M.
    Galletti, B.
    Cicala, M.
    di Prampero, Vadala S.
    Gualberti, G.
    Caprioli, F.
    Gasbarrini, A.
    Meregaglia, M.
    VALUE IN HEALTH, 2014, 17 (07) : A570 - A571
  • [28] Health-related quality of life after ileocolonic resection for Crohn's disease:: Long-term results
    Scarpa, Marco
    Ruffolo, Cesare
    D'Inca, Renata
    Filosa, Teresa
    Bertin, Eugenia
    Ferraro, Stefania
    Polese, Lino
    Martin, Alessandro
    Sturniolo, Giacomo C.
    Frego, Mauro
    D'Amico, Davide F.
    Angriman, Imerio
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (04) : 462 - 469
  • [29] Clinically meaningful improvements in health-related quality of life from etanercept therapy for patients with moderate to severe psoriasis
    Feldman, SR
    Kimball, A
    Woolley, JM
    Zitnik, R
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P155 - P155
  • [30] USTEKINUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: RESULTS FROM A WEEK 16 INTERIM ANALYSIS OF THE STARDUST TRIAL
    Danese, Silvio
    Vermeire, Severine
    D'Haens, Geert
    Panes, Julian
    Dignass, Axel
    Magro, Fernando
    Nazar, Maciej
    Le Bars, Manuela
    Lahaye, Marjolein
    Ni, Lioudmila
    Gaya, Daniel R.
    Peyrin-Biroulet, Laurent
    GASTROENTEROLOGY, 2021, 160 (06) : S409 - S409
12345